Xela Rederm
by Yuria-pharm LLC Ukraine EUDAMED
Ref 2SNModel Injectable implant based on hyaluronic acid XELA REDERM 1,1% 2 ml
EMDN P900402
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDD | NumberB-000034545XELAREDER2SNZN | Date9 Jul 2026 | StatusActive |
Coverage
- Expiring (legacy directive)
- Not covered
European Union — CE/MDD Expiring (legacy directive)
EU market availability
Available in 12 countries, as listed in EUDAMED:
- Croatiasince 2 Nov 2023
- Cyprussince 24 Jan 2023
- Finlandsince 9 Feb 2023
- Italysince 20 Jul 2022
- Latviasince 26 Jul 2022
- Lithuaniasince 7 Jul 2022
- Netherlandssince 28 Feb 2023
- Polandsince 22 Aug 2022
- Romaniasince 16 Jan 2023
- Sloveniasince 2 Nov 2023
- Spainsince 8 Mar 2023
- Swedensince 16 Mar 2023
Specification
- Device Name
- Injectable implant based on hyaluronic acid XELA REDERM
- Model / Reference
- Injectable implant based on hyaluronic acid XELA REDERM 1, 1% 2 ml, 2SN
- Primary DI / UDI-DI
- D-000034545XELAREDER2SNZN
- Basic UDI-DI
- B-000034545XELAREDER2SNZN
- EMDN Code
- P900402 Resorbable filling and reconstruction devices
- Device Class
- Class III
- Market of Registration
- Lithuania
Manufacturer details
- EUDAMED SRN
- UA-MF-000034545
- Authorised representative
- Diaco Biofarmaceutici srl IT-AR-000021064
Other devices from Yuria-pharm LLC
Properties & raw data
Show properties, registry sources and raw records
Other properties (9)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No
Sources (1)
- EUDAMED D-000034545XELAREDER2SNZN|B-000034545XELAREDER2SNZN